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Abstract
Objetive: Coronary artery bypass grafting (CABG) with 
cardiopulmonary bypass (CPB) improved symptoms and increased 
survival and quality of life in patients with coronary artery 
disease. However, it should be the main cause of a complex 
organic systemic inflammatory response that greatly contributes 
to several postoperative adverse effects. 
Methods: We aimed to evaluate heat-shock protein 70 (HSP 70) 
expression as a morbimortality predictor in patients with preserved 
ventricular function undergoing coronary artery bypass grafting 
(CABG) with cardiopulmonary bypass (CPB) and to determine their 
association with the lactate as a marker of tissue hypoperfusion 
and the EuroSCORE risk score. This is a prospective, observational 
study including 46 patients and occurring between May and 
July 2016. Patients without ventricular dysfunction undergoing 
myocardial revascularization with extracorporeal circulation 
were included. They were divided into (1) complicated and (2) 
uncomplicated postoperative evolution groups. EuroSCORE, 
lactate levels, and HSP 70 expression and their correlations were 
determined.
Results: Statistical analysis showed that the group with 
complicated evolution had higher EuroSCORE values than the 
other group. HSP 70 protein levels were significantly increased 
in the group with uncomplicated evolution and showed similar 
results. According to our results, HSP family proteins may be 
independent predictors of uncomplicated evolution in patients 
without ventricular dysfunction undergoing CABG with CPB.
Conclusion: HSP 70 should be a good discriminator and 
protection marker for complications in cardiac surgery.
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Therefore, we aimed to evaluate HSP 70 expression as a 
morbimortality predictor in patients with preserved ventricular 
function undergoing CABG with CPB and to determine their 
association with the lactate as a marker of tissue hypoperfusion 
and EuroSCORE risk score.
METHODS
Study Design and Protocol
The study protocol was evaluated and approved by the 
Graduate Teaching and Research Committee of the Federal 
University of Grande Dourados (UFGD) and the Ethics Committee 
for Analysis of Research Projects on Human Subjects of the 
University of Campinas (UNICAMP). The protocol was registered 
on the ‘Plataforma Brasil’ research website (CAAE Registry No. 
50344015.8.3001.5404). A prospective, observational study 
was conducted between May and July 2016 at the Hospital 
Evangélico Dr. e Sra. Goldsbyking (Dourados, MS, Brazil).
The patients were then divided into two groups, 
according to their postoperative evolution: (1) patients with 
complicated evolution and (2) those with uncomplicated 
evolution. Complicated evolution was defined as death during 
hospitalization or in the first 30 days after surgery and/or the 
presence of one or more postoperative complications that 
resulted in prolonged intensive care unit (ICU) hospitalization 
(length of stay > 4 days). All other cases were considered 
uncomplicated. The post-surgery outcomes were compared 
between the groups.
Patients’ Recruitment
During the study period, 93 patients scheduled to undergo 
cardiac surgery with CPB in the institution were selected. After 
applying the exclusion criteria, 52 patients were considered 
eligible for the study. Among them, two patients did not sign 
the informed consent form and four patients were excluded 
due to data loss. Thus, 46 patients were included. The study 
inclusion criteria included adult patients without left ventricular 
dysfunction who were scheduled to undergo CABG with CPB. 
All subjects gave written informed consent to participate in the 
study and were informed (orally and in detail) by the researchers 
about the nature, investigative character, objectives, results, and 
risks of the study.
The exclusion criteria comprehended patients with chronic 
or acute renal failure (serum creatinine levels ≥ 1.4 g/dL), hepatic 
failure, uncontrolled diabetes mellitus, pulmonary diseases 
(chronic obstructive pulmonary disease or previous pulmonary 
surgery), neurological diseases (stroke, dementia, or psychosis), 
history of fever or recent infection (up to 1 week prior to surgery), 
presence of cardiogenic shock or mechanical complications 
of infarction, abnormal ejection fraction (< 55%), and non-
compliance with the method on the part of the patient.
Surgery Protocol
The standard pre-anesthetic medication was 1 mg 
alprazolam, administered orally 8 hours before surgery; no 
medication was administered to patients with unstable 
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INTRODUCTION
Coronary heart disease is the main cause of mortality in the 
global population[1]. In recent decades, coronary artery bypass 
grafting (CABG) with cardiopulmonary bypass (CPB) have 
improved symptoms and increased survival rate and quality of 
life[2]. However, this surgical method is considered a cause of a 
complex organ system inflammatory response that contributes 
to several postoperative adverse effects, which include renal, 
pulmonary, neurological, and hemorrhagic complications[3]. In 
spite of significant changes and improvements in CPB systems, 
complications involving tissue damage persist, affecting 
postoperative morbidity and mortality[4]. Complications caused 
by CPB, such as bleeding, hemodilution, and low cardiac output, 
are related to tissue hypoxia and organ dysfunctions[5,6].
To assess morbidity and mortality during cardiac surgery, 
several models of risk stratification have been developed[3,7,8]. 
EuroSCORE is a simple, objective, effective, and safe instrument 
even when applied to non-European populations[9]. In Brazil, it 
is used as postoperative morbidity and mortality predictor[9,10]. 
However, because there are multiple and complex intraoperative 
and postoperative factors involved and the prognosis needs to 
be safely assessed, it is necessary to evaluate tissue perfusion 
by ideally simple and accessible methods that can provide 
information to complement the EuroSCORE.
Lactate is widely used as a systemic indicator to evaluate the 
metabolism. Nonetheless, its clinical interpretation should be 
cautious because although it assesses the severity of the clinical 
situation, it is nonspecific, and the isolated measurement does not 
benefit the prognostic evaluation[11]. Serial measurements and 
comparison of their values provide a significant understanding 
of the case’s severity[12].
Heat-shock proteins (HSP) belong to the chaperone 
family of proteins present in the body cells. They correspond 
to approximately 1%–2% of the constituent proteins in non-
stressed cells and 4%–6% of the proteins in stressed cells. High 
molecular weight HSP (HSP 100, 90, 70, and 60) are adenosine 
triphosphate (ATP)-dependent, whereas low molecular weight 
HSP (HSP 20, 25, and 27) are ATP-independent[13]. They provide 
the cell with great tolerance and resistance against a variety of 
aggressor agents, maintaining the cell’s integrity and structure, 
besides promoting cell survival during stress periods[14].
Because HSP can respond to different types of stress, which 
include heart disease, its potential as a diagnostic and prognostic 
marker in heart disease has been proposed[15,16].
There is a great interest in understanding the role of HSP in 
the inflammatory response that occurs during cardiac surgery 
with CPB. Several studies have demonstrated an increase in the 
production of pro-inflammatory cytokines after CPB[17].
Among the HSP types, HSP 70 is the most studied intracellular 
chaperone molecule. Many efforts have been directed at assessing 
its capacity for protecting the cardiac tissue undergoing ischemic 
preconditioning[18]. Experimental results suggest that the effect 
of moderate hypothermia during CPB involves upregulation of 
HSP 70 with inhibition of necrosis, but not of apoptosis[19]. HSP 70 
levels are associated with tissue damage and ischemia following 
cardiac surgery and their measurement may present a diagnostic 
and prognostic advantage in these cases[20].
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The following postoperative complications were observed: 
prolonged hospital stay (defined as hospital discharge after 
the 10th postoperative day), prolonged ICU stay (defined as 
ICU discharge after the 4th postoperative day), prolonged 
tracheal intubation time (defined as mechanical ventilation for 
more than 6 hours after admission to ICU or need for tracheal 
reintubation), neurological complications (focal or global 
neurological deficit documented within 48 hours after surgery 
or delirium), infectious complications (surgical wound infection, 
mediastinitis, pneumonia, urinary tract infection, and/or sepsis 
with no identified focus, according to the standards established 
by the Hospital Infection Control Committee), low cardiac output 
(defined as a cardiac index < 2.2 L/min/m2, difficulty in weaning 
from inotropic medications 24 hours after surgery, or the need 
for IAB use), arrhythmias (presence of arrhythmia requiring the 
use of antiarrhythmic agents and/or the need for defibrillation 
or electrical cardioversion), and acute kidney failure (defined as 
an increase in serum creatinine levels > 50% of the preoperative 
value or the need for hemodialysis).
Serum lactate levels were analyzed by arterial gasometry 
using the potentiometric method, with a reference value of 
5.7–2.0 mg/dL or 0.63–2.44 mmol/L. The equipment used for the 
measurements was the Radiometer® ABL 700 gasometer.
Western Blot Analysis
Myocardial biopsy for HSP assessment was performed 
on the free wall of the right atrium. The sample was obtained 
immediately after pericardial opening, prior to the administration 
of heparin and/or any surgical manipulation of the heart. 
Samples were preserved in liquid nitrogen and stored at -70°C 
until analysis. The frozen samples were homogenized in 20 
volumes of 600 mmol/L sodium chloride and 15 mmol/L Tris 
(hydroxymethyl aminomethane); pH was 7.5. Protein levels were 
determined using the technique described by Lowry et al.[21] and 
bovine serum albumin was used as a standard.
From each patient selected in this study, a 1 mL serum 
sample was collected during atrial biopsy for assessing 
circulating HSP 70 levels. Next, 1 μL of each protease inhibitor 
(phenylmethanesulfonyl fluoride [PMSF], aprotinin, leupeptin) 
was added to each plasma aliquot prior to freezing in a -80°C 
freezer. HSP 70 levels in the culture medium were determined 
using an ultra-sensitive specific kit (HSP70 EKS-715), and the 
result was normalized by the number of cells in each one and 
the incubation period, expressed as ng/h/108 cells.
The Western blot test was conducted as follows: the atrial 
muscle (200 mg) was homogenized in 1 mL of buffer (200 mM 
ethylenediaminetetraacetic acid [EDTA] [Sigma 03685], pH 7.0), 1 
M Tris Base (Bio-Rad # 161-0719, pH 7.5), 10 mM orthovanadate 
(Sigma S6508), 2 mM PMSF (Sigma P7626), 10 mM sodium 
pyrophosphate (Sigma 221368), 0.1 mg/mL aprotinin (Sigma 
10820), 100 mM sodium fluoride (Sigma 71519), 10% Triton 
(Sigma # 019K0151), and ultrapure water. The test used a polytron 
(Pro Scientific model 200) and centrifuged the solution (Sigma, 
2K15 model, serial number 57707, Germany) at 14,000 g for 40 
min at 4°C; at this point, the supernatant was collected. The total 
protein content in the supernatant was determined using the 
Lowry method[21].
hemodynamic conditions. The anesthetic technique chosen was 
balanced general anesthesia. After denitrogenation with 100% 
oxygen, anesthetic induction was performed with etomidate 
(2 mg/kg), midazolam (0.05 mg/g), sufentanil (0.5 μg/kg), or 
fentanyl (5 μg/kg), and pancuronium (0.1 mg/kg) was used as 
a neuromuscular blocker. The patients were then intubated and 
maintained on mechanical ventilation with a fraction of inspired 
oxygen of 60% in the valvular circulatory system with carbon 
dioxide (CO2) absorber, volume-controlled and pressure-limited 
ventilation (25 mmHg), tidal volume ranging from 6 to 8 mL/kg, 
respiratory rate of 12 cycles per minute, positive end-expiratory 
pressure of 5 mmHg, and gas flow of 1.0 L/min. Anesthesia 
was maintained using varying isoflurane concentrations 
(0.5%–1%) and intermittent doses of sufentanil or fentanyl and 
pancuronium. Before CPB, a new aliquot of midazolam and a 
neuromuscular blocker were administered.
Intraoperative hydration was performed with Ringer's lactate 
based on filling pressures, diuresis, and cardiac output. The red 
blood cell transfusion threshold was established as hemoglobin 
(Hb) < 7 mg/dL, in patients without hemodynamic instability, 
and Hb < 9 mg/dL, in those with hemodynamic instability.
Before CPB, patients underwent anticoagulation therapy 
with heparin (Liquemine®) at a dose of 300 IU/kg to maintain 
activated coagulation time (ACT) > 480 s, supplemented with 
doses of 5,000–10,000 IU when necessary (ACT < 480 s). At 
the end of CPB, anticoagulation was reversed with protamine 
hydrochloride at a 1:1 ratio of the initial dose. Patients underwent 
median sternotomy; CPB was initiated with cannulation of the 
ascending aorta and right atrium, and cannulation of the right 
upper pulmonary vein was initiated with the introduction of a 
catheter for aspiration and decompression of the left ventricle. 
Membrane oxygenators were used in all patients during CPB. The 
temperature during CPB was maintained between 32°C and 34°C, 
and the myocardial protection technique used was intermittent 
hypothermic antegrade cardioplegia. The management of the 
acid-base balance during CPB was performed using the alpha-
stat method. Infusion was maintained with non-pulsatile flow 
of approximately 2.2–2.4 L/min/m to maintain a mean blood 
pressure of approximately 60 mmHg.
To remove the patient from CPB, vasoactive and inotropic 
drugs were used according to the patient's needs; this decision 
was left to the discretion of the anesthesiologist.
Outcomes
The following preoperative clinical data were recorded: 
EuroSCORE; age; gender; weight; body surface area (BSA); left 
ventricular ejection fraction; history of previous cardiac surgeries; 
and use of intra-aortic balloon (IAB), inotropic and/or vasopressor 
drugs, and nitroglycerin.
During surgery, the patient’s temperature, heart rate, cardiac 
rhythm, urinary output, arterial blood pressure (through the radial 
artery), and central venous pressure (through the subclavian 
vein) were measured. Intraoperative data were collected in the 
operating room, and postoperative data were collected in the 
surgical ICU of the same institution. After surgery, patients were 
monitored until discharge, and postoperative complications 
during the hospitalization period were recorded.
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RESULTS
Of the 46 patients studied, 32 were men (69.5%) and 14 
were women (30.4%). The ages of the patients ranged from 35-
83 years old. The general characteristics were presented in Table 
1. The mean age in the group of patients with complications 
was 66.3 ± 10 years while the mean age in the group of those 
without complications was 59.7 ± 9.4 years (P=0.002). Although a 
different value was observed, there was no statistically significant 
difference in BSA or in the proportion of female patients between 
the groups.
The group with complicated evolution presented higher 
EuroSCORE values (median, 5; interquartile range [IR], 3-5) than 
the group with uncomplicated evolution (median, 3; IR, 3-5). No 
differences were observed between the groups with respect to 
surgery, anesthesia, aortic clamping, and CPB duration (Table 2).
During the postoperative follow-up, 31 patients were 
classified as having uncomplicated evolution (67.3%) and 15 
patients had complicated evolution (32.6%), three of whom died 
within 30 days of surgery, one of neurological complication and 
two of infectious complications (Table 3). The other postoperative 
parameters that configure the differences between the groups 
were presented in Table 3.
Statistical Analysis
In the statistical analysis, continuous variables were presented 
as means ± standard deviations or as medians and interquartile 
ranges when data did not follow a Gaussian distribution. 
Categorical variables were presented as proportions.
Continuous variables were analyzed using Student's t-test or non-
parametric Mann-Whitney test; categorical variables were analyzed 
using Fisher’s exact test or the chi-squared test, when appropriate. 
Parameters that presented a difference between the groups with 
P<0.05 in the univariate analysis were included in the multivariate 
analysis, which was performed using a logistic regression model 
(backward Wald) to identify independent markers for complicated 
evolution. The logistic regression results were described as odds ratio 
(OR) and at a 95% confidence interval (95% CI).
Receiver operating characteristic (ROC) curves of parameters 
identified as complicated evolution predictors were constructed to 
find the best cut-off points associated with complicated evolution. 
The cut-off point was determined as the value associated with the 
highest sum of sensitivity and specificity. Areas under the ROC curve 
were determined and compared. The analysis was performed using 
the Statistical Package for Social Sciences software, version 17.0. A 
P-value < 0.05 was considered statistically significant.
Table 1. General characteristics of the patients’ groups.
Variable
Uncomplicated 
evolution (n = 31)
Complicated 
evolution (n = 15)
P Test
Age (years)a 59.7±9.4 66.3±10 0.002 Student’s t-test
BSA (m2)a 1.81±0.17 1.71±0.16 0.06 Student’s t-test
Weight (kg)b 74 (65.5–80) 65 (60–73.5) 0.005 Mann-Whitney
Female genderc 8 (25.8%) 6 (40%) 0.13 Chi-squared
Ejection fraction (VF) 58±1.3 56±1.2 0.25 Mann-Whitney
aValues A1:E18 mean ± standard deviation; bmedian values and interquartile range; cabsolute value (percentages)
BSA=body surface area; VF=ventricular fibrillation







EuroSCOREb 3 (3–5) 6 (5–8) <0.001 Mann–Whitney
IABc 3 (6.1%) 4 (10.5%) 0.71 Fisher’s test
Inotropic and/or 
vasopressor drugsc
1 (3.0%) 3 (20%) 0.44 Fisher’s test
Nitroglycerinc 4 (13%) 2 (12.5%) 0.92 Fisher’s test
Intraoperative
Surgery duration 280 (240–340) 312 (245–374) 0.24 Mann-Whitney
Anesthesia duration 390 (320–430) 400 (334–480) 0.38 Mann-Whitney
CPB time (min)b 95 (75–118) 90 (69–140) 0.77 Mann-Whitney
bMedian values and interquartile range; cabsolute value (percentages)
CPB=cardiopulmonary bypass; IAB=intra-aortic balloon
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the ROC curve demonstrate that EuroSCORE and HSP 70 variables 
were protective factors for the occurrence of complications. These 
findings indicate that EuroSCORE and HSP 70 variables presented 
excellent discrimination power, as observed in Table 4.
The qualitative expression of HSP 70 showed that the level 
of protein was correlated to the outcome of post-surgery 
evolution, as shown in the Figure 6. The non-complicated group 
showed higher bands expressions of serum and atrial HSP 70 
levels (Figure 7) than the complicated group.
The dispersion plot of correlation between serum and atrial 
HSP 70 expression showed a moderate and non-significant 
coefficient of relationship (P>0.05) (Figure 8). Linear regression 
equation is presented in the Figure 8.
The area under the curve was 0.841 (95% CI: 0.725–0.956). 
This indicates that the EuroSCORE has a high power to 
predict complications. The chance that a patient will present 
complications increases by 2.09 times with each additional 
EuroSCORE point. This is a strong independent risk and prognosis 
predictor, as shown in Figure 1.
Arterial lactate levels were significantly higher in the group 
with complicated evolution than in the other group. Baseline 
levels of lactate were 452 ± 88 in the uncomplicated group and 
510 ± 105 µM in the complicated group (P=0.40). Despite being 
increased in the complicated group, the delta lactate showed no 
significant difference in lactate levels between the groups. The 
results indicate that there was a significant increase in arterial 
lactate levels during surgery in both groups, but this was not an 
independent predictor of complications. As shown in Figure 2, 
the area under the curve was 0.558 (95% CI: 0.386–0.73), and its 
accuracy was not significant in this sample.
The significant increase in HSP 70 expression was observed 
in the group with uncomplicated evolution. HSP 70 content was 
significantly higher in patients who did not develop complication 
(34±12 vs. 18±14; P=0.006). HSP 70 area under the curve was 
0.683 (95% CI: 528–0.839), with a sensitivity of 93% of protection. 
These results held true even in peripheral plasma (37±12 vs. 
22±15, P=0.01). HSP 70 presented the same expression in the 
peripheral plasma with an area under the curve of 0.687 (95% CI: 
0.377–0.715) and a significant sensitivity of 93%, as observed in 
Figures 3 and 4, respectively.
In our study, atrial biopsy was obtained immediately after 
opening the pericardium, before administration of heparin-
initiation of CPB. Inducible HSP 70 level in such relatively 
unstressed atrial myocytes reflects initial expression of HSP 70 and 
possibly represents a more efficient stress handling mechanism 
at the disposal of these cells. Soluble HSP 70 concentrations may 
be a marker of cell injury induced by severe stress and are not 
reflective of intracellular levels; this is the difference in ROC curve 
for atrial vs. serum HSP 70 in Figure 5.
From the univariate CI, it was observed that variable lactate levels 
were not risk factors for patients with complications. Areas under 








Duration of ICU stay (days)a 2 (2–4) 8 (7–21) <0.001
In-hospital length of stay (days)a 7 (6–13) 21 (14–28) <0.001
Prolonged intubationb 18 (41%) 11 (75%) <0.001
Renal complicationsb 1 (3%) 8 (51%) <0.001
Neurological complicationsb 0 (0%) 4 (26%) <0.001
Infectious complicationsb 9 (29%) 11 (73%) <0.001
Low cardiac outputb 3 (9.6%) 13 (86.6%) <0.001
Arrhythmiasb 2 (6.4%) 9 (60%) <0.001
 aValues in median and interquartile range; bAbsolute value (percentage)
CABG=coronary artery bypass grafting; CPB=cardiopulmonary bypass; ICU=intensive care unit
Fig. 1 – EuroSCORE receiver operating characteristic (ROC) curves to 
predict complications.
161
Brazilian Journal of Cardiovascular Surgery 
HSP 70 expression seems to be a good way to measure the 
complication risk. This study evaluated the expression of HSP 70 
in the myocardium and peripheral blood and its association with 
postoperative evolution. This protein shows a low expression in 
patients with complicated evolution.
Braz J Cardiovasc Surg 2019;34(2):156-64Cantero MA, et al. - Heat-Shock Proteins as Predictors of Post-Surgery 
Evolution
DISCUSSION
CABG with CPB is a highly effective treatment for coronary 
insufficiency; however, it has a non-negligible potential 
for complications. The identification of markers of these 
complications can minimize or even prevent them and the 
Fig. 2 – Lactate receiver operating characteristic (ROC) curves to 
predict complications.
Fig. 3 – Atrial heat-shock protein 70 (HSP 70) expressions receiver 
operating characteristic (ROC) curves to predict complications.
Fig. 4 – Serum heat-shock protein 70 (HSP 70) receiver operating 
characteristic (ROC) curves to predict complications.
Fig. 5 – Serum and atrial heat-shock protein 70 (HSP 70) receiver 
operating characteristic (ROC) curves to predict complications.
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in cardiac surgery[22,23] and the results of the present study are 
in agreement with the literature. The chance of complication 
increased by 2.09 times with each increased unit of EuroSCORE; 
values > 5 were predictors of complicated evolution in patients 
with normal ventricular function who underwent myocardial 
revascularization. EuroSCORE has also presented excellent 
sensitivity for the detection of complications in patients 
undergoing CABG in this population[9,10]. Present data confirm 
these findings, with a sensitivity of > 90%.
EuroSCORE consists of a risk stratification model developed 
for predicting hospital mortality after cardiac surgery[7-9], and 
it was an independent predictor of complicated evolution for 
this patient population. Several studies have demonstrated 
the validity of its use as a predictor of postoperative morbidity 
Fig. 7 – Atrial and serum heat-shock protein 70 (HSP 70) expression 
in the complicated (C) and non-complicated (NC) group. BSA=body 
surface area
Fig. 8 – Linear regression between serum and atrial heat-shock 
protein 70 (HSP) 70 expression.
Table 4. Statistical analysis of the markers studied.
Variable Univariate regression (95% CI) Multivariate regression (95% CI)
OR LL UL P-value OR LL UL P-value
EuroSCORE 2.097 1.326 3.316 0.002 1.99 1.259 3.147 0.003
Lactate 1.573 0.978 2.529 0.062 1.449 0.744 2.82 0.276
Atrial HSP 70 0.787 0.666 0.929 0.005 1.146 0.71 1.85 0.577
Serum HSP 70 0.71 0.501 1.004 0.053 1.25 0.704 2.219 0.446
CI=confidence interval; HSP 70=heat-shock protein 70; LL=lower limit; OR=odds ratio; UL=upper limit
Fig. 6 – Myocardial expression of heat-shock protein 70 (HSP 70) and evolution outcome. C=complicated; NC=non-complicated
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findings suggest that because HSP 70 levels are inherently high in 
patients with more favorable evolution and there is a correction 
with EuroSCORE, any protective benefit that can be derived from 
this protein can already be measured. This is in agreement with 
the literature[32]. The development of mechanisms that increase 
tolerance to perioperative damage may result in a more advanced 
method to attenuate CPB-induced inflammation and minimize this 
problem; measures that increase HSP 70 expression can be part of 
these mechanisms.
CONCLUSION
The present findings demonstrate that some predictors, such as 
EuroSCORE, are independent complication predictors. Furthermore, 
the myocardial or serum HSP 70 levels can be considered as 
independent predictors of uncomplicated evolution in patients 
without ventricular dysfunction who undergo CABG, thereby 
providing additional information on the prognosis of these patients.
We conclude that the HSP 70, whether myocardial or 
serum (the latter being more feasible to measure), may be a 
relevant biomarker. A better understanding of the role of HSP 
in the inflammation caused by CPB may provide the possibility 
of predicting and helping prevent an adverse event in the 
immediate postoperative period following cardiac surgery.
It is believed that the identification of patients at high risk of 
complications during cardiac surgery using scores and known 
markers, associated with other predictors with strong predictive 
power, may allow for the adoption of early measures aimed at 
better tissue perfusion, resulting in a shorter ICU stay and better 
prognosis for patients undergoing myocardial revascularization.
The arterial lactate level tended to be higher in the group with 
complicated evolution than in the group with uncomplicated 
evolution, although no statistically significant differences were 
observed. Approximately 10%–20% of patients present high lactate 
levels and postoperative morbimortality[6]. Although there was an 
increase in lactate levels in the group with complicated evolution, 
it was not consistent enough to be considered as an independent 
prognosis predictor. This absence of statistical significance may be 
explained by the limitation of the analysis, which was restricted to 
the intraoperative period. This period was too short to allow for 
arterial lactate clearance or to study its kinetics.
The results of this study suggest that HSP 70 is an 
independent uncomplicated evolution predictor after myocardial 
revascularization in patients with normal left ventricular function. 
This marker presented a sensitivity of > 93%, which constitutes a 
protection factor.
High levels of HSP 70 are related to lower damage caused by 
ischemia[24]. The presence of postoperative complication seems 
to be associated with low levels of HSP70. After inducing HSP 70 
overexpression, Okubo et al. demonstrated a significant reduction 
in the infracted area[24]. The ischemic heart appears to be less 
capable of producing HSP 70, a factor which could be closely 
related to the decrease of the ability to tolerate stress after a 
surgery[25]. Experimental results suggest that the effect of moderate 
hypothermia during CPB involves the regulation of the HSP 70 
protein family, with the inhibition of necrosis, but not of apoptosis[19]. 
HSP 70 levels have previously been associated with tissue damage 
and ischemia following cardiac surgery, and its measurement may 
be a diagnostic and prognostic advantage in these cases[20].
The differences in HSP 70 expression and its correlation with 
postoperative evolution may be influenced by the groups, since 
ageing negatively regulate the HSP 70 expression in heart and 
can cause the heart to be more susceptible to oxidative and stress 
damage[26]. This can reinforce our argument that an increase in HSP 
70 expression should be a cardioprotection mechanism, because 
the complicated evolution group showed higher age. The other 
possible influence was the group’s sex prevalence. Sex hormone 
alters the expression of HSP 70 differently in women and men[27]. 
However, it’s unclear if the men are more sensitive to induction of 
HSP 70 expression by the inhibitory effect of estrogen on the HSP 70 
expression[28] or if the women hormone doesn’t have this inhibitory 
effect and other factors are involved in upregulation of HSP 70 
expression[29].
Circulating HSP 70 may indicate cellular stress or damage. 
Furthermore, HSP are suggested as immunoregulatory agents, 
and may be important in the host defense postoperatively[30]. The 
effects of two different cardioplegia techniques on myocardial HSP 
70 messenger ribonucleic acid (mRNA) levels suggest that there was 
a significant increase in HSP 70 mRNA levels in response to CPB in 
both groups[31]. However, we didn’t find a causal correlation between 
atrial and serum HSP 70 expression. The inductions of expression 
of this protein are tissue-specific and the circulation levels can be 
influenced by other origins. New study researches should explore 
if the increase in the HSP 70 cardiac expression may positively or 
negatively regulate the serum protein expressions.
The mechanism of HSP 70 expression preconditioning to increase 
success of cardiac surgery interventions is unclear but the present 
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